4
Changes in Ownership
Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-24-005284
Chief Financial Officer acquired 1,787 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Moran Sean F. Chief Financial Officer | 2024-04-10 | Option exercise | +1,787 | $30.00 | $53,610 | 48,605 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Moran Sean F. Chief Financial Officer | 2024-04-10 | Option exercise · Employee Stock Option (right to buy) | −1,787 | 0 | D: show line 2 in the form |
Loading xslF345X05/doc4.xml…